GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » Common Stock

YSB (HKSE:09885) Common Stock : HK$0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB Common Stock?

YSB's quarterly common stock stayed the same from Dec. 2023 (HK$0 Mil) to Jun. 2024 (HK$0 Mil) but then increased from Jun. 2024 (HK$0 Mil) to Dec. 2024 (HK$0 Mil).

YSB's annual common stock increased from Dec. 2022 (HK$0 Mil) to Dec. 2023 (HK$0 Mil) and increased from Dec. 2023 (HK$0 Mil) to Dec. 2024 (HK$0 Mil).


YSB Common Stock Historical Data

The historical data trend for YSB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB Common Stock Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
- - - 0.01 0.01

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Common Stock Get a 7-Day Free Trial - 0.01 0.01 0.01 0.01

YSB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


YSB Business Description

Traded in Other Exchanges
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Zhang Buzhen 2501 Other
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V, L.p. 2101 Beneficial owner
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
Shleifer Scott 2201 Interest of corporation controlled by you
Internet Fund Holding V. Ltd. 2201 Interest of corporation controlled by you
Tiger Global Management, Llc 2102 Investment manager
Tiger Global Pip Performance Xi, L.p. 2201 Interest of corporation controlled by you
Tiger Global Private Investment Partners Xi, L.p. 2101 Beneficial owner
Coleman Iii Charles 2201 Interest of corporation controlled by you
Miyt Worldwide Limited 2201 Interest of corporation controlled by you
Tmf (cayman) Ltd. 2301 Trustee
Internet Fund V Pte. Ltd. 2306 Nominee for another person
Miyt Holdings Limited 2101 Beneficial owner

YSB Headlines

No Headlines